Concert Pharma Balance Sheet - Quarterly (NASDAQ:CNCE)

Add to My Stocks
$13.52 $0.23 (1.67%) CNCE stock closing price Sep 21, 2018 (Closing)

The Concert Pharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Concert Pharma stock analysis, and provides insights into the firm's financial performance. A company releases its balance sheet every quarter along with its quarterly results. Concert Pharma balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of 0 and debt to equity ratio of 0. Also check Concert Pharma revenue and Concert Pharma operating cash flow for the same period.

View and download Concert Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash58.35M35.69M27.66M32.11M27.59M28.1M40.55M29.8M53.65M37.82M
Marketable Securities131.81M164.46M175.5M174.99M75.82M55.82M55.63M78.18M64.76M89.89M
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets18.28M18.59M1.78M1.92M2.31M2.3M1.35M1.43M1.31M2.3M
Total Current Assets
208.99M219.46M205.73M209.67M106.22M86.42M97.72M109.76M120.08M130.55M
Property Plant & Equipment--9.53M---9.07M---
Accumulated Depreciation--7.36M---6.87M---
Net Property Plant & Equipment
7.69M4.35M2.16M2.11M1.94M2.14M2.19M2.17M2.12M2.24M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets3.82M3.82M3.83M-------
Total Assets
220.51M227.64M211.73M212.22M108.62M89.03M100.39M112.36M122.63M133.29M
Notes Payable----------
Accounts Payable1.08M---1M1.52M-1.44M2.4M-
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.38M4.2M4.29M3.4M3.9M2.21M3.85M4.23M3.38M3.45M
Income Taxes Payable---2.17M------
Other Current Liabilities1.41M1.41M1.44M1.38M1.16M1.15M1.17M1.21M1.22M1.25M
Total Current Liabilities
6.16M6.57M6.44M7.44M6.07M4.9M5.57M6.89M7M5.47M
Mortgages----------
Deferred Taxes/Income10.54M9.83M8.85M8.92M8.89M8.94M8.98M8.99M9.02M9.06M
Convertible Debt----------
Long-Term Debt----29.18M-----
Non-Current Capital Leases----------
Other Long-Term Liabilities3.52M---------
Total Liabilities
20.23M17.24M15.3M16.36M44.24M14.01M14.8M16.22M16.44M15.03M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus278.86M275.81M273.05M266.08M262.64M260.24M257.46M255.92M254.6M253.25M
Retained Earnings-78.27M-64.95M-76.24M-70.17M-198.24M-185.21M-171.88M-159.83M-148.48M-135.04M
Treasury Stock----------
Other Liabilities-0.32M-0.48M-0.4M-0.06M-0.04M-0.03M-0.01M---
Shareholders Equity200.28M210.39M196.43M195.86M64.38M75.02M85.59M96.14M106.18M118.26M
Total Liabilities & Shareholders Equity220.51M227.64M211.73M212.22M108.62M89.03M100.39M112.36M122.63M133.29M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Concert Pharma stock price, and Concert Pharma historical stock prices show the stock price movement over time, and the Concert Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Concert Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for CNCE stock as of 2018 Q2 is $220.51M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Concert Pharma for the quarter 2018 Q2 total to $20.23M. Liabilities for a company like Concert Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Concert Pharma Balance Sheet - Key Ratios

Current ratio
33.87
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
244.97
Price to book ratio
1.82